Oishi T - Search Results

1

Deep vein thrombosis and serum D-dimer after pelvic lymphadenectomy in gynecological cancer.

Komatsu H, Shimada M, Osaku D, Deura I, Sato S, Oishi T, Harada T. Komatsu H, et al. Among authors: oishi t. Int J Gynecol Cancer. 2020 Jun;30(6):860-864. doi: 10.1136/ijgc-2019-000914. Epub 2020 Apr 9. Int J Gynecol Cancer. 2020. PMID: 32276932

2

Alteration of telomerase activity associated with development and extension of epithelial ovarian cancer.

Oishi T, Kigawa J, Minagawa Y, Shimada M, Takahashi M, Terakawa N. Oishi T, et al. Obstet Gynecol. 1998 Apr;91(4):568-71. doi: 10.1016/s0029-7844(98)00044-1. Obstet Gynecol. 1998. PMID: 9540942

3

Indication and efficacy of radiation therapy following radical surgery in patients with stage IB to IIB cervical cancer.

Okada M, Kigawa J, Minagawa Y, Kanamori Y, Shimada M, Takahashi M, Oishi T, Terakawa N. Okada M, et al. Among authors: oishi t. Gynecol Oncol. 1998 Jul;70(1):61-4. doi: 10.1006/gyno.1998.5005. Gynecol Oncol. 1998. PMID: 9698475 Clinical Trial.

4

A newly developed adenovirus-mediated transfer of a wild-type p53 gene increases sensitivity to cis-diamminedichloroplatinum (II) in p53-deleted ovarian cancer cells.

Kanamori Y, Kigawa J, Minagawa Y, Irie T, Oishi T, Shimada M, Takahashi M, Nakamura T, Sato K, Terakawa N. Kanamori Y, et al. Among authors: oishi t. Eur J Cancer. 1998 Oct;34(11):1802-6. doi: 10.1016/s0959-8049(98)00199-3. Eur J Cancer. 1998. PMID: 9893672

5

Alteration of telomerase activity in ovarian cancer after chemotherapy.

Takahashi M, Kigawa J, Oishi T, Itamochi H, Shimada M, Sato S, Kamazawa S, Akeshima R, Terakawa N. Takahashi M, et al. Among authors: oishi t. Gynecol Obstet Invest. 2000;49(3):204-8. doi: 10.1159/000010247. Gynecol Obstet Invest. 2000. PMID: 10729763

6

Alteration of a p53 gene status affects outcome of patients with recurrent ovarian cancer.

Irie T, Kigawa J, Minagawa Y, Oishi T, Takahashi M, Shimada M, Kamazawa S, Sato S, Terakawa N. Irie T, et al. Among authors: oishi t. Oncology. 2000 Apr;58(3):237-41. doi: 10.1159/000012106. Oncology. 2000. PMID: 10765126

7

Telomerase activity and p53-dependent apoptosis in ovarian cancer cells.

Akeshima R, Kigawa J, Takahashi M, Oishi T, Kanamori Y, Itamochi H, Shimada M, Kamazawa S, Sato S, Terakawa N. Akeshima R, et al. Among authors: oishi t. Br J Cancer. 2001 Jun 1;84(11):1551-5. doi: 10.1054/bjoc.2001.1812. Br J Cancer. 2001. PMID: 11384107 Free PMC article.

8

Chemosensitivity and p53-Bax pathway-mediated apoptosis in patients with uterine cervical cancer.

Sultana H, Kigawa J, Kanamori Y, Itamochi H, Oishi T, Sato S, Kamazawa S, Ohwada M, Suzuki M, Terakawa N. Sultana H, et al. Among authors: oishi t. Ann Oncol. 2003 Feb;14(2):214-9. doi: 10.1093/annonc/mdg071. Ann Oncol. 2003. PMID: 12562647 Free article.

9

Activity of docetaxel in paclitaxel-resistant ovarian cancer cells.

Sato S, Kigawa J, Kanamori Y, Itamochi H, Oishi T, Shimada M, Iba T, Naniwa J, Uegaki K, Terakawa N. Sato S, et al. Among authors: oishi t. Cancer Chemother Pharmacol. 2004 Mar;53(3):247-52. doi: 10.1007/s00280-003-0714-9. Epub 2003 Nov 11. Cancer Chemother Pharmacol. 2004. PMID: 14610615

10

Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.

Shimada M, Kigawa J, Takahashi M, Minagawa Y, Okada M, Kanamori Y, Itamochi H, Oishi T, Iba T, Terakawa N. Shimada M, et al. Among authors: oishi t. Gynecol Oncol. 2004 Jun;93(3):628-31. doi: 10.1016/j.ygyno.2004.03.011. Gynecol Oncol. 2004. PMID: 15196855 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

823 results

Search Page

Filters